Cardiovascular risk factors underestimate atherosclerotic burden in chronic kidney disease: Usefulness of non-invasive tests in cardiovascular assessment

Nephrology Dialysis Transplantation

Volumn 25, Issue 9, 2010, Pages 3017-3025

  Coll, Blai ^a   Betriu, Ángels ^a   Martínez Alonso, Montserrat ^b   Borrs, Merc ^a   Craver, Lourdes ^a   Amoedo, Maria Luisa ^c   Marco, Mpaz ^a   Sarró, Felipe ^a   Junyent, Mireia ^a   Valdivielso, Jose Manuel ^a   Fernández, Elvira ^a  

^a Unitat de Diagnstic i Tractament de Malalties Aterotrombtiques (UDETMA)   (Spain)

^b HOSPITAL UNIVERSITARI ARNAU DE VILANOVA   (Spain)

^c HOSPITAL DE TORREVIEJA   (Spain)

Author keywords

ankle brachial index; atherosclerosis; carotid ultrasound; chronic kidney diseases

Indexed keywords

C REACTIVE PROTEIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTICLE; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CHRONIC KIDNEY DISEASE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIALYSIS; DISEASE SEVERITY; FEMALE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SCORING SYSTEM; ULTRASOUND;

ADULT; AGED; ANKLE BRACHIAL INDEX; ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CAROTID ARTERIES; CASE-CONTROL STUDIES; CHRONIC DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; MALE; MIDDLE AGED; PREVALENCE; PROGNOSIS; RISK FACTORS; SPAIN; SURVIVAL RATE;

EID: 77956244160     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq109     Document Type: Article

References (28)

1. Go AS, Chertow GM, Fan D, McCullock CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
2. Iseki K, Yamazato M, Tozawa M, Takishita S. Hypocholesterolemia is a significant predictor of death in a cohort of chronic hemodialysis patients. Kidney Int 2002; 61: 1887-1893
3. Cheung AK, Sarnak MJ, Yan G, Dwyer JT, Heyka RJ, Rocco MV, et al. Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients. Kidney Int 2000; 58: 353-362
4. Astor BC, Coresh J, Heiss G, Pettitt D, Sarnak MJ. Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 2006; 151: 492-500
5. Cottone S, Lorito MC, Riccobene R, Nardi E, Mul G, Buscemi S et al. Oxidative stress, inflammation and cardiovascular disease in chronic renal failure. J Nephrol 2008; 21: 175-179
6. De Boer IH, Kestenbaum B, Schoben AB, Michos ED, Sarnak MJ, Siscovick DS. 25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol 2009; 20: 1805-1812
7. Valdivielso JM, Coll B, Fernandez E. Vitamin D and the vasculature: can we teach an old drug new tricks? Expert Opin Ther Targets 2009; 13: 29-38
8. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work GroupKDIGO clinical practice guideline for the diagnosis evaluation, prevention and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int 2009; 76: S1-S130
9. Early detection of atherosclerosis: a randomized trial in the primary prevention of cardiovascular diseases (PRIMARIA). NCT00734123. http://www.clintrials.gov
10. Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R et al. European guidelines on cardiovascular disease prevention in clinical practice: fourth joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Prevention in Clinical Practice. Eur J Cardiovasc Prev Rehabil 2007; 28: 2375-2414
11. Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N et al. Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 2007; 23: 75-80
12. The kidney disease outcomes quality initiative clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39: S1-S266
13. Junyent M, Gilabert R, Núñez I, Corbella E, Vela M, Zambón D, et al. Carotid ultrasound in the assessment of preclinical atherosclerosis. Distribution of intima-media thickness values and plaque frequency in a Spanish community cohort. Med Clin (Barc) 2005; 125: 770-774
14. Howard G, Burke GL, Evans GW, Crouse JR 3rd, Riley W, Arnett D et al. Relations of intimal-medial thickness among sites within the carotid artery as evaluated by B-mode ultrasound. ARIC Investigators. Stroke 1994; 25: 1581-1587
15. Ix JH, Katz R, De Boer IH, Kestenbaum IR, Allison MA, Siscovick DS et al. Association of chronic kidney disease with the spectrum of ankle brachial index the CHS (Cardiovascular Health Study). J Am Coll Cardiol 2009; 54: 1176-1184
16. Kraniak A, Drozdz M, Pasowicz M, Chmiel G, Michaek M, Szumilak D et al. Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients. Nephrol Dial Transplant 2007; 22: 515-521
17. Pascazio L, Bianco F, Giorgini A, Galli G, Curri G, Panzetta G. Echo color Doppler imaging of carotid vessels in hemodialysis patients: evidence of high levels of atherosclerotic lesions. Am J Kidney Dis 1996; 28: 713-720
18. Leskinen Y, Lehtimäki T, Loimaala A, Lautamatti V, Kallio T, Huhtala H et al. Carotid atherosclerosis in chronic renal failure-the central role of increased plaque burden. Atherosclerosis 2003; 171: 295-302
19. Witko-Sarsat V, Friedlander M, Nguyen Khoa T, Capeillere-Blandin C, Nguyen AT, Canteloup S et al. Advanced oxidation protein products as novel mediators of inflammation and monocyte activation in chronic renal failure. J Immunol 1998; 161: 2524-2532
20. Akdag I, Yilmaz Y, Kahvecioglu S, Bolca N, Ercan I, Ersoy A et al. Clinical value of the malnutrition-inflammation-atherosclerosis syndrome for long-term prediction of cardiovascular mortality in patients with end-stage renal disease: a 5-year prospective study. Nephron Clin Pract 2008; 108: c99-c105
21. K/DOQI clinical practice guidelines for managing dyslipidemias in chronic kidney disease. Am J Kidney Dis 2003; 41: S11-S21
22. National Cholesterol Education Program (NCEP) Expert Panel (ATP III). Executive Summary of the Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Eval-uation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486-2497
23. Granada JF, Feinstein SB. Imaging of the vasa vasorum. Nat Clin Pract Cardiovasc Med 2008; 5: S18-S25
24. Wanner C, Krane V, Marz W, Olschewski M, Mann JF, Ruf G et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis. N Engl J Med 2005; 353: 238-248
25. Asselbergs FW, Diercks GF, Hillege HL, van Boven AJ, Janssen WM, AA BROS et al. Effects of fosinopril and pravastatin on cardiovascular events in subjects with microalbuminuria. Circulation 2004; 110: 2809-2816
26. Fellstrm BC, Jardine AG, Schmieder RE, Holdaas H, Bannister K, Beutler J et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis. N Engl J Med 2009; 360: 1395-1407
27. Baigent C, Landry M. Study of Heart and Renal Protection (SHARP). Kidney Int Suppl 2003S207-S210
28. Preston E, Ellis MR, Kulinskaya E, Davies AH, Brown EA. Association between carotid artery intima-media thickness and cardiovascular risk factors in CKD. Am J Kidney Dis 2005; 46: 856-862